Gene expression profiling upon 212Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model

Cancer Medicine

Volumn 2, Issue 5, 2013, Pages 646-653

  Yong, Kwon J ^a   Milenic, Diane E ^a   Baidoo, Kwamena E ^a   Kim, Young Seung ^a   Brechbiel, Martin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

212PB-TCMC-TRASTUZUMAB; DISSEMINATED INTRAPERITONEAL DISEASE; GENE EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEAD RADIOISOTOPES; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RADIOIMMUNOTHERAPY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907056720     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.132     Document Type: Article

References (27)